Torrent Pharmaceuticals · NSE: TORNTPHARM · BSE: 500420
Q2 FY19 results · Jul–Sep 2018
Torrent Pharmaceuticals reported revenue from operations of ₹1,894.00 crore and net profit of ₹179.00 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,894.00 | — | — | 1,872.00 | +1.2% |
| Other income | 10.00 | — | — | 27.00 | −63.0% |
| Total income | 1,904.00 | — | — | 1,899.00 | +0.3% |
| Profit before tax | 205.00 | — | — | 232.00 | −11.6% |
| Net profit for the period | 179.00 | — | — | 163.00 | +9.8% |
| EPS, basic (₹) | 10.57 | — | — | 9.66 | +9.4% |
| Net margin (%) | 9.5 | — | 8.7 |
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,472.00 | — | — | 1,452.00 | +1.4% |
| Other income | 108.00 | — | — | 34.00 | +217.6% |
| Total income | 1,580.00 | — | — | 1,486.00 | +6.3% |
| Profit before tax | 300.00 | — | — | 188.00 | +59.6% |
| Net profit for the period | 277.00 | — | — | 122.00 | +127.0% |
| EPS, basic (₹) | 16.38 | — | — | 7.21 | +127.2% |
| Net margin (%) | 18.8 | — | 8.4 |
Consolidated
- Filed with BSE
- 04 Nov 2018, 17:19 IST
- Board meeting
- 03 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Nov 2018, 17:19 IST
- Board meeting
- 03 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Audited
- Source
- XBRL filing on BSE